Rating Rationale
February 27, 2024 | Mumbai
 
Samrat Pharmachem Limited
'CRISIL BB+/Stable/CRISIL A4+' assigned to Bank Debt
 
Rating Action
Total Bank Loan Facilities Rated Rs.30 Crore
Long Term Rating CRISIL BB+/Stable (Assigned)
Short Term Rating CRISIL A4+ (Assigned)
Note: None of the Directors on CRISIL Ratings Limited’s Board are members of rating committee and thus do not participate in discussion or assignment of any ratings. The Board of Directors also does not discuss any ratings at its meetings.
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities
*Issuer did not cooperate; based on best-available information

 

Detailed Rationale

CRISIL Ratings has assigned its 'CRISIL BB+/Stable/CRISIL A4+' ratings to the bank facilities of Samrat Pharmachem Ltd (SPL).

 

The ratings reflect the established market position of the company and extensive experience of the promoters in the iodine manufacturing industry and a healthy financial risk profile. These strengths are partially offset by susceptibility to volatility in raw material prices and foreign exchange (forex) rates and large working capital requirements.

Key Rating Drivers & Detailed Description

Strengths:

  • Established market position and extensive experience of the promoters: The company has been manufacturing iodine derivatives for three decades. This has helped the promoters develop keen understanding of market dynamics and healthy relationships with suppliers and customers. Over the years, SPL has increased its product range to various industrial segments such as pharmaceuticals, fast-moving consumer goods (FMCG), animal feed and agrochemicals. This has led to improvement in revenue profile with average growth of 28% over the last five fiscals to Rs 310.75 crore in fiscal 2023 from Rs 92.7 crore in fiscal 2018. The company has achieved revenue of Rs 198.9 crore in the nine months of fiscal 2024 and is expected to achieve revenue of Rs 275-280 crore for the full fiscal 2024.

 

  • Healthy financial risk profile: Capital structure was strong owing to lower reliance on external debt, yielding gearing and total outside liabilities to adjusted networth ratio of 0.30 time and 0.84 time, respectively, with networth of Rs 63.15 crore as on March 31, 2023. Debt protection metrics were adequate, as reflected in interest coverage and net cash accrual to total debt ratios of 19.63 times and 0.90 times, respectively, in fiscal 2023. The financial risk profile will remain comfortable over the medium term supported by steady accretion to reserve and nil debt-funded capital expenditure (capex) planned.

 

Weaknesses:

  • Susceptibility to volatility in raw material prices and forex rates: Clientele comprises larger, established players leading to limited pricing power for SPL. Furthermore, limited complexity of operations constrains profitability. The price of the major raw material, iodine, is volatile and depends on global demand and supply. Operating margin remained in the range of 3-7% over the three fiscals through 2023 and stood at 0.57% in the nine months of fiscal 2024. The operating margin will remain a key monitorable.

 

Since the majority of procurement comes from the international market, sharp fluctuation in forex rates affects procurement cost and accrual. This exposes the operating margin to fluctuations in forex rates.

 

  • Moderate working capital cycle: Gross current assets were at 115.7-96.34 days over the three fiscals ended March 31, 2023. Its moderate working capital management is reflected in its gross current assets (GCA) of 115.7 days, with inventory and receivable of 41 and 60 days respectively as on March 31, 2023. It is required to extend the long credit period in line with the industry standards. As the customers are small and medium-sized players who require credit. Furthermore, to meet its business requirements, it hold large work in process & inventory.

Liquidity: Adequate

Bank limit utilisation was low at 29% on average for the 12 months through December 2023. Cash accrual is expected to be over Rs 7 crore per annum against nil term debt obligation over the medium term and will cushion liquidity. Current ratio was healthy at 1.87 times as on March 31, 2023. Low gearing and moderate networth support financial flexibility, which will help to withstand adverse conditions or downturns in the business.

Outlook: Stable

CRISIL Ratings believes SPL will continue to benefit from the extensive experience of its promoters and established relationships with clients.

Rating Sensitivity Factors

Upward factors

  • Sustained improvement in scale of operation by 15-20% with operating margin reaching 7-8%, leading to higher cash accruals.
  • Improvement in the working capital cycle.

 

Downward factors

  • Decline in net cash accrual below Rs 2.5 crore on account of fall in revenue or operating profit.
  • Large, debt-funded capex weakening the capital structure.
  • Further stretch in the working capital cycle weakening liquidity and financial risk profile.

About the Company

SPL was incorporated in June 1992 at Ankleshwar in Gujarat. The company is promoted by Mr Lalit Mehta and Mr Rajesh Mehta. It manufactures iodine compounds used in pharmaceuticals, FMCG, animal feed, chemicals and agrochemicals. The company became a public limited company in 1995 and is listed on the Bombay Stock Exchange.

Key Financial Indicators

As on/for the period ended March 31

Unit 

2023

2022

Operating income

Rs.Crore

310.75

222.18

Reported profit after tax

Rs.Crore

16.63

17.18

PAT margins

%

5.35

7.73

Adjusted Debt/Adjusted Networth

Times

0.30

0.16

Interest coverage

Times

19.63

36.69

Any other information: Not Applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings` complexity levels are assigned to various types of financial instruments and are included (where applicable) in the 'Annexure - Details of Instrument' in this Rating Rationale.

CRISIL Ratings will disclose complexity level for all securities - including those that are yet to be placed - based on available information. The complexity level for instruments may be updated, where required, in the rating rationale published subsequent to the issuance of the instrument when details on such features are available.

For more details on the CRISIL Ratings` complexity levels please visit www.crisilratings.com. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of instrument

Date of

allotment

Coupon

rate (%)

Maturity

date

Issue size

(Rs.Cr)

Complexity

Levels

Rating assigned with

outlook

NA

Cash Credit*

NA

NA

NA

28

NA

CRISIL BB+/Stable

NA

Foreign Exchange Forward

NA

NA

NA

2

NA

CRISIL A4+

*Letter of Credit limit is fully interchangeable with Cash Credit limit.

Annexure - Rating History for last 3 Years
  Current 2024 (History) 2023  2022  2021  Start of 2021
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities ST/LT 30.0 CRISIL BB+/Stable / CRISIL A4+ 11-01-24 Withdrawn (Issuer Not Cooperating)*   -- 30-12-22 CRISIL BB+ /Stable / CRISIL A4+ (Issuer Not Cooperating)*   -- CRISIL BB+/Stable
      --   --   -- 26-04-22 CRISIL BBB-/Stable / CRISIL A3   -- --
      --   --   -- 11-03-22 Withdrawn (Issuer Not Cooperating)*   -- --
      --   --   -- 31-01-22 CRISIL BB+ /Stable(Issuer Not Cooperating)*   -- --
Non-Fund Based Facilities ST   --   --   -- 30-12-22 CRISIL A4+ (Issuer Not Cooperating)*   -- --
      --   --   -- 26-04-22 CRISIL A3   -- --
All amounts are in Rs.Cr.
* - Issuer did not cooperate; based on best-available information
Annexure - Details of Bank Lenders & Facilities
Facility Amount (Rs.Crore) Name of Lender Rating
Cash Credit* 28 ICICI Bank Limited CRISIL BB+/Stable
Foreign Exchange Forward 2 ICICI Bank Limited CRISIL A4+
*Letter of Credit limit is fully interchangeable with Cash Credit limit.
Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
CRISILs Criteria for rating short term debt
Understanding CRISILs Ratings and Rating Scales

Media Relations
Analytical Contacts
Customer Service Helpdesk

Aveek Datta
Media Relations
CRISIL Limited
M: +91 99204 93912
B: +91 22 3342 3000
AVEEK.DATTA@crisil.com

Prakruti Jani
Media Relations
CRISIL Limited
M: +91 98678 68976
B: +91 22 3342 3000
PRAKRUTI.JANI@crisil.com

Rutuja Gaikwad 
Media Relations
CRISIL Limited
B: +91 22 3342 3000
Rutuja.Gaikwad@ext-crisil.com


Nitin Kansal
Director
CRISIL Ratings Limited
D:+91 124 672 2154
nitin.kansal@crisil.com


Nilesh Agarwal
Associate Director
CRISIL Ratings Limited
D:+91 79 4024 4531
nilesh.agarwal1@crisil.com


Jinagna Dixit Shah
Rating Analyst
CRISIL Ratings Limited
B:+91 79 4024 4500
Jinagna.Shah@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper/magazine/agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites and portals.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited, an S&P Global Company)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as bank loans, certificates of deposit, commercial paper, non-convertible/convertible/partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including ratings for municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ('CRISIL Ratings') is a wholly-owned subsidiary of CRISIL Limited ('CRISIL'). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 

 



About CRISIL Limited

CRISIL is a leading, agile and innovative global analytics company driven by its mission of making markets function better. 

It is India’s foremost provider of ratings, data, research, analytics and solutions with a strong track record of growth, culture of innovation, and global footprint.

It has delivered independent opinions, actionable insights, and efficient solutions to over 100,000 customers through businesses that operate from India, the US, the UK, Argentina, Poland, China, Hong Kong and Singapore.

It is majority owned by S&P Global Inc, a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.

For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address and email id to fulfil your request and service your account and to provide you with additional information from CRISIL. For further information on CRISIL's privacy policy please visit www.crisil.com.



DISCLAIMER

This disclaimer is part of and applies to each credit rating report and/or credit rating rationale ('report') that is provided by CRISIL Ratings Limited ('CRISIL Ratings'). To avoid doubt, the term 'report' includes the information, ratings and other content forming part of the report. The report is intended for the jurisdiction of India only. This report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the report or of the manner in which a user intends to use the report. In preparing our report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the report is not intended to and does not constitute an investment advice. The report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind to enter into any deal or transaction with the entity to which the report pertains. The report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold or sell any securities/instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. The rating contained in the report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the report should rely on their own judgment and take their own professional advice before acting on the report in any way. CRISIL Ratings or its associates may have other commercial transactions with the entity to which the report pertains.

Neither CRISIL Ratings nor its affiliates, third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively, 'CRISIL Ratings Parties') guarantee the accuracy, completeness or adequacy of the report, and no CRISIL Ratings Party shall have any liability for any errors, omissions or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the report. EACH CRISIL RATINGS PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. Public ratings and analysis by CRISIL Ratings, as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any), are made available on its website, www.crisilratings.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and/or relies on in its reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for managing conflict of interest. For details please refer to:
https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html.

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public website, www.crisilratings.com. For latest rating information on any instrument of any company rated by CRISIL Ratings, you may contact the CRISIL Ratings desk at crisilratingdesk@crisil.com, or at (0091) 1800 267 1301.

This report should not be reproduced or redistributed to any other person or in any form without prior written consent from CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings is a wholly owned subsidiary of CRISIL Limited.

 

 

CRISIL Ratings uses the prefix 'PP-MLD' for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011, to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: https://www.crisil.com/en/home/our-businesses/ratings/credit-ratings-scale.html